We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Report Predicts Double-Digit Growth for Protein Microarrays

By LabMedica International staff writers
Posted on 19 Jan 2015
Microarrays are in great demand for studying the workings of proteins, to discover new biomarkers and even new drugs, and for diagnostics. More...
Among the tests useful in protein analysis, microarrays were among the fastest revenue growth category, according to Kalorama Information’s (New York, NY, USA) latest report “Proteomics Markets Research and IVD Applications.”

Protein microarrays are arrays of proteins or peptides immobilized onto a solid surface such as a glass slide, membrane, microtiter plate, or other solid surface. The market for proteomics instruments, reagents, and testing topped USD 5 billion in 2013. Also according to the report, while the entire market will grow at high single-digits, the microarray market within proteomics will grow at 15% revenue growth per year for the next 5 years.

“The proteomics market is expected to continue to grow as researchers continue to work on basic understanding of the human proteome, and as researchers apply these discoveries in fields such as biomarker discovery and validation, drug discovery and development, diagnostics, and personalized medicine,” said Bruce Carlson, publisher of Kalorama Information.

The report identifies three main types of protein microarrays. Analytical microarrays: Analytical protein (or antibody) microarrays use immobilized antibodies to detect proteins in biological samples, often via use of a secondary antibody in principle similar to a sandwich immunoassay. Functional microarrays: With functional protein microarrays purified recombinant proteins are immobilized onto the solid phase. These microarrays can then be used to study enzymatic activity or to identify protein-protein (or peptide), protein-DNA, protein-RNA, protein-phospholipid, protein-drug, or other interactions with the immobilized proteins. They can also be used to detect antibodies in a biological specimen to profile an immune response. Protein lysate microarrays (also called reverse-phase protein microarrays): Complex samples such as lysates from tissues or cells are arrayed onto the solid phase, and then probed with antibodies to a target protein of interest.

Companies have used microarray principles, combined with their own proprietary technologies, to develop a wide range of protein microarrays. Kalorama Information's report features more than 20 firms involved in development and marketing of protein microarrays, detailing products and expected earnings for companies involved in microarrays and other proteomics. The report contains breakouts of the market by type of technology used and application. It profiles companies and surveys partnerships and deals related to proteomics.

Related Links:

Kalorama Information
Proteomics Markets for Research and IVD Applications, report



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.